Could combining Pfizer's and AZ's COVID-19 vaccines fill supply gaps? U.K. researchers aim to find out Primary care docs are key to accelerating the COVID-19 vaccine rollout: study These were the specialties that used telehealth the most in 2020: study Roche's COVID-19 diagnostics boosted 2020 sales despite other testing losses Roche hit by worst-case biosim assault—to the tune of $5.6B—as COVID-19 hurts new king Ocrevus Biopharma roundup—Novavax inks new supply deal Cigna execs say COVID-19 costs outstripped savings from lower utilization at end of 2020 From Louisiana bayous to Manhattan, docs say getting COVID-19 vaccines is a waiting game. Here's one who succeeded Featured Story | By Arlene Weintraub Oxford researchers have launched a trial designed to determine whether Pfizer's mRNA vaccine against COVID-19 can be used alongside AstraZeneca's viral-vector vaccine. They hope the 13-month trial will also reveal whether the two technologies might work in tandem to tackle new COVID variants. read more |
| |
|---|
|
| | Webinar: The Benefits of Pharmacist-Led Clinical Trials Tuesday, February 23, 2021 | 1pm ET / 10am PT This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now. |
Top Stories By Heather Landi Vaccinating millions of Americans against the COVID-19 virus is proving to be a complicated process already plagued with many setbacks. But there's a ready-made vaccine distribution system that can be tapped into to accelerate the rollout: primary care doctors. read more By Robert King A study released this week in the journal Health Affairs gives a look at who flocked to telemedicine from January to June 2020 and what types of patients employed the technology. read more By Conor Hale The company launched 15 different tests for COVID-19 over the past year, including both rapid, point-of-care solutions and high-throughput, centralized laboratory diagnostics. read more By Angus Liu Before biosimilars to Herceptin, Avastin and Rituxan arrived in the U.S., Roche laid out an expected range of damage to its cancer franchise. By the look of the first post-biosim year’s numbers, the company was hit with its worst-case scenario. read more By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale Roche's 2020 sales for some key drugs were affected by the pandemic as fewer patients switched to new offerings and some patients delayed treatment. Meanwhile, Novavax unveiled a new vaccine supply deal and Merck warned about using an anti-parasite medicine against COVID-19. read more By Paige Minemyer Cigna earned $4.1 billion in profit for the fourth quarter of 2020. That figure fell short of Wall Street analysts' expectations. read more By Heather Landi In a bayou community so isolated, it's actually called Cut Off, Louisana, Dr. Gary Birdsall has been singularly focused on getting his hands on the one thing his rural patients desperately need: doses of the COVID-19 vaccine. So has Dr. Mark Horowitz, 1,400 miles away in New York City. This week, one of these doctors succeeded. read more |
